Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
Chinese Patent Office
Cantor Fitzgerald
US Department of Justice
Cipla
Daiichi Sankyo
Colorcon
Merck

Generated: January 19, 2018

DrugPatentWatch Database Preview

Abbott Company Profile

« Back to Dashboard

What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and thirteen approved drugs.



Summary for Abbott
US Patents:0
Tradenames:91
Ingredients:64
NDAs:113

Drugs and US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070656-001 Jan 24, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott AMINOSYN-HBC 7% IN PLASTIC CONTAINER amino acids INJECTABLE;INJECTION 019400-001 Jul 23, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 089579-001 Apr 11, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019119-001 Oct 11, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089575-001 Feb 22, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott VERCYTE pipobroman TABLET;ORAL 016245-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate INJECTABLE;INJECTION 019712-001 Sep 8, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-003 Nov 22, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott PENTOTHAL thiopental sodium SUSPENSION;RECTAL 011679-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott IBUPROFEN ibuprofen TABLET;ORAL 071264-001 Jul 25, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott THYPINONE protirelin INJECTABLE;INJECTION 017638-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-001 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-003 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-004 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-001 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-004 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-002 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-002 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 100 mg ➤ Subscribe 10/31/2012
➤ Subscribe Tablets 100 mg ➤ Subscribe 12/21/2010
➤ Subscribe Capsules 10 mg and 15 mg ➤ Subscribe 8/14/2009
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Baxter
Colorcon
AstraZeneca
Medtronic
Covington
Argus Health
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot